Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 140

1.

An adult autosomal recessive chronic granulomatous disease patient with pulmonary Aspergillus terreus infection.

Mortaz E, Sarhifynia S, Marjani M, Moniri A, Mansouri D, Mehrian P, van Leeuwen K, Roos D, Garssen J, Adcock IM, Tabarsi P.

BMC Infect Dis. 2018 Nov 8;18(1):552. doi: 10.1186/s12879-018-3451-8.

2.

Treatment correlates of successful outcomes in pulmonary multidrug-resistant tuberculosis: an individual patient data meta-analysis.

Collaborative Group for the Meta-Analysis of Individual Patient Data in MDR-TB treatment–2017, Ahmad N, Ahuja SD, Akkerman OW, Alffenaar JC, Anderson LF, Baghaei P, Bang D, Barry PM, Bastos ML, Behera D, Benedetti A, Bisson GP, Boeree MJ, Bonnet M, Brode SK, Brust JCM, Cai Y, Caumes E, Cegielski JP, Centis R, Chan PC, Chan ED, Chang KC, Charles M, Cirule A, Dalcolmo MP, D'Ambrosio L, de Vries G, Dheda K, Esmail A, Flood J, Fox GJ, Fréchet-Jachym M, Fregona G, Gayoso R, Gegia M, Gler MT, Gu S, Guglielmetti L, Holtz TH, Hughes J, Isaakidis P, Jarlsberg L, Kempker RR, Keshavjee S, Khan FA, Kipiani M, Koenig SP, Koh WJ, Kritski A, Kuksa L, Kvasnovsky CL, Kwak N, Lan Z, Lange C, Laniado-Laborín R, Lee M, Leimane V, Leung CC, Leung EC, Li PZ, Lowenthal P, Maciel EL, Marks SM, Mase S, Mbuagbaw L, Migliori GB, Milanov V, Miller AC, Mitnick CD, Modongo C, Mohr E, Monedero I, Nahid P, Ndjeka N, O'Donnell MR, Padayatchi N, Palmero D, Pape JW, Podewils LJ, Reynolds I, Riekstina V, Robert J, Rodriguez M, Seaworth B, Seung KJ, Schnippel K, Shim TS, Singla R, Smith SE, Sotgiu G, Sukhbaatar G, Tabarsi P, Tiberi S, Trajman A, Trieu L, Udwadia ZF, van der Werf TS, Veziris N, Viiklepp P, Vilbrun SC, Walsh K, Westenhouse J, Yew WW, Yim JJ, Zetola NM, Zignol M, Menzies D.

Lancet. 2018 Sep 8;392(10150):821-834. doi: 10.1016/S0140-6736(18)31644-1. Review.

PMID:
30215381
3.

Risk Factors Associated with Survival of Pulmonary Tuberculosis.

Kazempour Dizaji M, Kazemnejad A, Tabarsi P, Zayeri F.

Iran J Public Health. 2018 Jul;47(7):980-987.

4.

miR-1224 Expression Is Increased in Human Macrophages after Infection with Bacillus Calmette-Guérin (BCG).

Alipoor SD, Mortaz E, Tabarsi P, Marjani M, Varahram M, Folkerts G, Garssen J, Adcock IM.

Iran J Allergy Asthma Immunol. 2018 Jun;17(3):250-257.

5.

Implementing Tuberculosis Close-contact Investigation in a Tertiary Hospital in Iran.

Shamaei M, Esmaeili S, Marjani M, Tabarsi P.

Int J Prev Med. 2018 May 16;9:48. doi: 10.4103/ijpvm.IJPVM_5_16. eCollection 2018.

6.

Investigating PIK3R3 and ATp2A1 Genes Expressions in Ventilator-Associated Pneumonia Patients Admitted to the Intensive Care Unit of Masih Daneshvari Hospital in 2016.

Jamaati H, Bahrami N, Daustany M, Tabarsi P, Farzanegan B, Hashemian SM, Mohamadnia A.

Rep Biochem Mol Biol. 2018 Apr;6(2):118-124.

7.

Comparison of different treatments for isoniazid-resistant tuberculosis: an individual patient data meta-analysis.

Fregonese F, Ahuja SD, Akkerman OW, Arakaki-Sanchez D, Ayakaka I, Baghaei P, Bang D, Bastos M, Benedetti A, Bonnet M, Cattamanchi A, Cegielski P, Chien JY, Cox H, Dedicoat M, Erkens C, Escalante P, Falzon D, Garcia-Prats AJ, Gegia M, Gillespie SH, Glynn JR, Goldberg S, Griffith D, Jacobson KR, Johnston JC, Jones-López EC, Khan A, Koh WJ, Kritski A, Lan ZY, Lee JH, Li PZ, Maciel EL, Galliez RM, Merle CSC, Munang M, Narendran G, Nguyen VN, Nunn A, Ohkado A, Park JS, Phillips PPJ, Ponnuraja C, Reves R, Romanowski K, Seung K, Schaaf HS, Skrahina A, Soolingen DV, Tabarsi P, Trajman A, Trieu L, Banurekha VV, Viiklepp P, Wang JY, Yoshiyama T, Menzies D.

Lancet Respir Med. 2018 Apr;6(4):265-275. doi: 10.1016/S2213-2600(18)30078-X. Erratum in: Lancet Respir Med. 2018 Apr 18;:.

PMID:
29595509
8.

Cellular immune response in MDR-TB patients to different protein expression of MDR and susceptible Mycobacterium tuberculosis: Rv0147, a novel MDR-TB biomarker.

Hadizadeh Tasbiti A, Yari S, Siadat SD, Tabarsi P, Saeedfar K, Yari F.

Immunol Res. 2018 Feb;66(1):59-66. doi: 10.1007/s12026-017-8971-6.

PMID:
29178041
9.

Multi-Gene Expression in Anthracosis of the Lungs as One of the Risk Factors for Non-Small Cell Lung Cancer

Jamaati H, Bahrami N, Tabarsi P, Khosravi A, Kiani A, Abedini A, Ahmadi R, Sharifynia S, Mohamadnia A.

Asian Pac J Cancer Prev. 2017 Nov 26;18(11):3129-3133.

10.

Cost of Tuberculosis Treatment: Evidence from Iran's Health System.

Bay V, Tabarsi P, Rezapour A, Marzban S, Zarei E.

Osong Public Health Res Perspect. 2017 Oct;8(5):351-357. doi: 10.24171/j.phrp.2017.8.5.09. Epub 2017 Oct 31.

11.

Risk factors for mortality among tuberculosis patients co-infected with HIV.

Baghaei P, Moniri A, Marjani M, Javanmard P, Mansouri D, Tabarsi P.

Infect Dis (Lond). 2018 May;50(5):399-402. doi: 10.1080/23744235.2017.1404633. Epub 2017 Nov 20. No abstract available.

PMID:
29157075
12.

Evidence for M2 macrophages in granulomas from pulmonary sarcoidosis: A new aspect of macrophage heterogeneity.

Shamaei M, Mortaz E, Pourabdollah M, Garssen J, Tabarsi P, Velayati A, Adcock IM.

Hum Immunol. 2018 Jan;79(1):63-69. doi: 10.1016/j.humimm.2017.10.009. Epub 2017 Oct 31.

13.

Pulmonary Actinomycosis in a Patient with AIDS/HCV.

Tabarsi P, Yousefi S, Jabbehdari S, Marjani M, Baghaei P.

J Clin Diagn Res. 2017 Jun;11(6):OD15-OD17. doi: 10.7860/JCDR/2017/27593.10092. Epub 2017 Jun 1.

14.

Distribution scheme of antituberculosis drug resistance among HIV patients in a referral centre over 10 years.

Baghaei P, Tabarsi P, Moniri A, Marjani M, Farnia P, Jabbehdari S, Velayati AA.

J Glob Antimicrob Resist. 2017 Dec;11:116-119. doi: 10.1016/j.jgar.2017.06.010. Epub 2017 Jul 21.

PMID:
28739225
15.

Acute Epstein - Barr virus hepatitis without mononucleosis syndrome: a case report.

Moniri A, Tabarsi P, Marjani M, Doosti Z.

Gastroenterol Hepatol Bed Bench. 2017 Spring;10(2):147-149.

16.

Revision and Implementation of "Clinical Guideline for Tuberculosis and HIV in Prisons", Great Tehran Prison, Iran.

Farhoudi B, SeyedAlinaghi S, Tabarsi P, Mohraz M, Golrokhy R, Farnia M, Shahbazi M, Alasvand R, Ebrahimi B, Esfehani J, Tashakoriyan M.

Infect Disord Drug Targets. 2018;18(1):72-80. doi: 10.2174/1871526517666170518093529.

PMID:
28521672
17.

Bovis Bacillus Calmette-Guerin (BCG) infection induces exosomal miRNA release by human macrophages.

Alipoor SD, Mortaz E, Tabarsi P, Farnia P, Mirsaeidi M, Garssen J, Movassaghi M, Adcock IM.

J Transl Med. 2017 May 12;15(1):105. doi: 10.1186/s12967-017-1205-9.

18.

Paecilomyces formosus Infection in an Adult Patient with Undiagnosed Chronic Granulomatous Disease.

Heshmatnia J, Marjani M, Mahdaviani SA, Adimi P, Pourabdollah M, Tabarsi P, Mahdavi F, Jamaati H, Adcock IM, Garssen J, Velayati A, Mansouri D, Mortaz E.

J Clin Immunol. 2017 May;37(4):342-346. doi: 10.1007/s10875-017-0395-5. Epub 2017 Apr 20. No abstract available.

PMID:
28429104
19.

Tuberculosis in Solid Organ Transplantation.

Alizadeh AM, Marjani M, Moniri A, Baghaei P, Jabbehdari S, Javanmard P, Tabarsi P.

Tanaffos. 2016;15(3):124-127. Review.

20.

Pattern recognitions receptors in immunodeficiency disorders.

Mortaz E, Adcock IM, Tabarsi P, Darazam IA, Movassaghi M, Garssen J, Jamaati H, Velayati A.

Eur J Pharmacol. 2017 Aug 5;808:49-56. doi: 10.1016/j.ejphar.2017.01.014. Epub 2017 Jan 14. Review.

21.

Usefulness of pulmonary artery diameter in diagnosing pulmonary hypertension in patients admitted to tuberculosis intensive care unit.

Nowroozpoor A, Hshemian SM, Malekmohammad M, Marjani M, Tabarsi P, Jamaati H, Khoundabi B, Moniri A.

Int J Mycobacteriol. 2016 Dec;5 Suppl 1:S56. doi: 10.1016/j.ijmyco.2016.10.032. Epub 2016 Nov 25.

22.

Radiographic manifestations of Tuberculosis in HIV positive patients: Correlation with CD4+ T-cell count.

Bakhshayesh-Karam M, Tabarsi P, Mirsaiedi SM, Amiri MV, Zahirifard S, Mansoori SD, Masjedi MR, Velayati AA.

Int J Mycobacteriol. 2016 Dec;5 Suppl 1:S244-S245. doi: 10.1016/j.ijmyco.2016.11.027. Epub 2016 Dec 5.

23.

Using competing risks model and competing events in outcome of pulmonary tuberculosis patients.

Dizaji MK, Kazemnejad A, Tabarsi P, Zayeri F.

Int J Mycobacteriol. 2016 Dec;5 Suppl 1:S237. doi: 10.1016/j.ijmyco.2016.09.015. Epub 2016 Oct 28.

24.

Molecular drug susceptibility testing against the first-line (rifampin and isoniazid) and second-line (ciprofloxacin-amikacin and kanamycin) treatment in different subtypes of Mycobacterium simiae.

Farnia P, Malekshahian D, Tabarsi P, Seif S, Velayati AA.

Int J Mycobacteriol. 2016 Dec;5 Suppl 1:S215. doi: 10.1016/j.ijmyco.2016.11.006. Epub 2016 Nov 22.

25.

Investigation of urine lipoarabinomannan in human immunodeficiency virus patients with or without coinfection with Tuberculosis in Iran.

Tabarsi P, Marjani M, Moniri A, Farnia P, Dizaji MK, Garssen J, Adcock IM, Mortaz E.

Int J Mycobacteriol. 2016 Dec;5 Suppl 1:S186-S187. doi: 10.1016/j.ijmyco.2016.11.005. Epub 2016 Nov 22.

26.

The analysis of exosomal micro-RNAs in peripheral blood mononuclear cell-derived macrophages after infection with bacillus Calmette-Guérin by RNA sequencing.

Mortaz E, Alipoor SD, Tabarsi P, Adcock IM, Garssen J, Velayati AA.

Int J Mycobacteriol. 2016 Dec;5 Suppl 1:S184-S185. doi: 10.1016/j.ijmyco.2016.09.045. Epub 2016 Nov 11.

27.

HIV and tuberculosis trends and survival of coinfection in a referral center in Tehran: A 12-year study.

Baghaei P, Tabarsi P, Jabehdari S, Marjani M, Moniri A, Farnia P, Velayati AA.

Int J Mycobacteriol. 2016 Dec;5 Suppl 1:S16-S17. doi: 10.1016/j.ijmyco.2016.10.010. Epub 2016 Oct 27.

28.

Susceptibility to pulmonary tuberculosis: host genetic deficiency in tumor necrosis factor alpha (TNF-α) gene and tumor necrosis factor receptor 2 (TNFR2).

Ghamari E, Farnia P, Saif S, Marashian M, Ghanavi J, Tabarsi P, Farnia P, Velayati AA.

Int J Mycobacteriol. 2016 Dec;5 Suppl 1:S136-S137. doi: 10.1016/j.ijmyco.2016.09.038. Epub 2016 Nov 12.

29.

T cell cytokine responses in peripheral blood mononuclear cells from patients with multidrug-resistant tuberculosis following stimulation with proteins purified from Mycobacterium tuberculosis MDR clinical isolates.

Hadizadeh Tasbiti A, Yari S, Ghanei M, Siadat SD, Amanzadeh A, Tabarsi P, Saeedfar K, Bahrmand A.

Int J Mycobacteriol. 2016 Dec;5 Suppl 1:S132-S133. doi: 10.1016/j.ijmyco.2016.10.009. Epub 2016 Oct 27.

30.

Yield of mycobacteriological study in diagnosis of pleural tuberculosis among Human immune deficiency virus-infected patients.

Marjani M, Yousefzadeh A, Tabarsi P, Moniri A, Akbar Velayati A.

Int J Mycobacteriol. 2016 Dec;5 Suppl 1:S112-S113. doi: 10.1016/j.ijmyco.2016.09.043. Epub 2016 Nov 11.

31.

H1N1 Influenza Patient Saved by Extracorporeal Membrane Oxygenation: First Report from Iran.

Jahangirifard A, Hossein Ahmadi Z, Golestani Eraghi M, Tabarsi P, Marjani M, Moniri A, Nadji SA, Hashemian SM, Velayati AA.

J Tehran Heart Cent. 2016 Jul 6;11(3):153-156.

32.

Association of Mycobacterium infections in patients with Mendelian susceptibility to mycobacterial disease with venous thromboembolism.

Alinejad Dizaj M, Mahdaviani SA, Tabarsi P, Ahari H, Ebrahimi A, Nadji SA, Emami H, Mortaz E.

Microbiol Immunol. 2016 Oct;60(10):678-686. doi: 10.1111/1348-0421.12442.

33.

Cancers Related to Immunodeficiencies: Update and Perspectives.

Mortaz E, Tabarsi P, Mansouri D, Khosravi A, Garssen J, Velayati A, Adcock IM.

Front Immunol. 2016 Sep 20;7:365. eCollection 2016. Review.

34.

Radiologic manifestations of pulmonary tuberculosis in patients of intensive care units.

Hashemian SM, Tabarsi P, Karam MB, Kahkouee S, Marjani M, Jamaati H, Shekarchi N, Mohajerani SA, Velayati AA.

Int J Mycobacteriol. 2015 Sep;4(3):233-8. doi: 10.1016/j.ijmyco.2015.05.008. Epub 2015 Jun 19.

35.

Evaluation of Hepatoprotective Effect of Silymarin Among Under Treatment Tuberculosis Patients: A Randomized Clinical Trial.

Marjani M, Baghaei P, Kazempour Dizaji M, Gorji Bayani P, Fahimi F, Tabarsi P, Velayati AA.

Iran J Pharm Res. 2016 Winter;15(1):247-52.

36.

A randomized controlled trial of smoking cessation methods in patients newly-diagnosed with pulmonary tuberculosis.

Aryanpur M, Hosseini M, Masjedi MR, Mortaz E, Tabarsi P, Soori H, Emami H, Heidari G, Dizagie MK, Baikpour M.

BMC Infect Dis. 2016 Aug 5;16:369. doi: 10.1186/s12879-016-1727-4.

37.

Impact of diabetes mellitus on tuberculosis drug resistance in new cases of tuberculosis.

Baghaei P, Tabarsi P, Javanmard P, Farnia P, Marjani M, Moniri A, Masjedi MR, Velayati AA.

J Glob Antimicrob Resist. 2016 Mar;4:1-4. doi: 10.1016/j.jgar.2015.11.006. Epub 2015 Dec 13.

PMID:
27436384
38.

Reduced Phagocytic Capacity of Blood Monocyte/Macrophages in Tuberculosis Patients Is Further Reduced by Smoking.

Aryanpur M, Mortaz E, Masjedi MR, Tabarsi P, Garssen J, Adcock IM, Mozafarian A, Sharifi H.

Iran J Allergy Asthma Immunol. 2016 Jun;15(3):174-82.

39.

Prevalence of HLA-B*5701 and Its Relationship with Abacavir Hypersensitivity Reaction in Iranian HIV-Infected Patients.

Baniasadi S, Shokouhi SB, Tabarsi P, Alehashem M, Khalili H, Fahimi F, Nadji SA.

Tanaffos. 2016;15(1):48-52.

40.
41.

Intention to Quit Smoking and Associated Factors in Smokers Newly Diagnosed with Pulmonary Tuberculosis.

Aryanpur M, Masjedi MR, Mortaz E, Hosseini M, Jamaati H, Tabarsi P, Soori H, Heydari GR, Kazempour-Dizaji M, Emami H, Mozafarian A.

Tanaffos. 2016;15(1):17-24.

42.

ISG15 deficiency and increased viral resistance in humans but not mice.

Speer SD, Li Z, Buta S, Payelle-Brogard B, Qian L, Vigant F, Rubino E, Gardner TJ, Wedeking T, Hermann M, Duehr J, Sanal O, Tezcan I, Mansouri N, Tabarsi P, Mansouri D, Francois-Newton V, Daussy CF, Rodriguez MR, Lenschow DJ, Freiberg AN, Tortorella D, Piehler J, Lee B, García-Sastre A, Pellegrini S, Bogunovic D.

Nat Commun. 2016 May 19;7:11496. doi: 10.1038/ncomms11496.

43.

Diagnosing active and latent tuberculosis among Iranian HIV-infected patients.

Baghaei P, Esmaeili S, Farshidpour M, Javanmard P, Marjani M, Moniri A, Nemati K, Tabarsi P.

Clin Respir J. 2018 Jan;12(1):62-67. doi: 10.1111/crj.12479. Epub 2016 Apr 27.

PMID:
27059900
44.
45.

Current Recommendations for Pneumococcal Vaccination of Children and Adults.

Fakhraei H, Khalilzadeh S, Khanbabaei G, Mahmoudi S, Masjedi MR, Mehdizadeh M, Momenzadeh A, Nateghian A, Tabarsi P, Tabatabaei P, Yadegarinia D.

Tanaffos. 2015;14(3):161-4. No abstract available.

46.

Effect of Ventilation on Occupational Exposure to Airborne Biological Contaminants in an Isolation Room.

Jafari MJ, Hajgholami MR, Omidi L, Jafari M, Tabarsi P, Salehpour S, Amiri Z.

Tanaffos. 2015;14(2):141-8.

47.

Comparison of antibacterial activities of cadmium oxide nanoparticles against Pseudomonas Aeruginosa and Staphylococcus Aureus bacteria.

Salehi B, Mortaz E, Tabarsi P.

Adv Biomed Res. 2015 May 29;4:105. doi: 10.4103/2277-9175.157805. eCollection 2015.

48.

Recurrent Drug-Induced Hepatitis in Tuberculosis-Comparison of Two Drug Regimens.

Shamaei M, Mirsaeidi M, Baghaei P, Mosaei H, Marjani M, Tabarsi P.

Am J Ther. 2017 Mar/Apr;24(2):e144-e149. doi: 10.1097/MJT.0000000000000218.

49.

Impact of HIV infection on tuberculous pleural effusion.

Marjani M, Yousefzadeh A, Baghaei P, Tabarsi P, Moniri A, Masjedi MR, Velayati AA.

Int J STD AIDS. 2016 Apr;27(5):363-9. doi: 10.1177/0956462415581738. Epub 2015 May 8.

PMID:
25957323
50.

Screening for diabetes mellitus in tuberculosis patients in a referral center in Iran.

Baghaei P, Tabarsi P, Marjani M, Moniri A, Masjedi MR.

Infect Dis (Lond). 2015 Jul;47(7):472-6. doi: 10.3109/23744235.2015.1018317. Epub 2015 Mar 4.

PMID:
25738612

Supplemental Content

Loading ...
Support Center